Kleebayoon, A., & Wiwanitkit, V. BNT162b2 versus mRNA-1273 mRNA COVID-19 vaccines as the third booster for the patients with underlying cancer. Wolters Kluwer Medknow Publications.
Chicago Style (17th ed.) CitationKleebayoon, Amnuay, and Viroj Wiwanitkit. BNT162b2 Versus MRNA-1273 MRNA COVID-19 Vaccines as the Third Booster for the Patients with Underlying Cancer. Wolters Kluwer Medknow Publications.
MLA (9th ed.) CitationKleebayoon, Amnuay, and Viroj Wiwanitkit. BNT162b2 Versus MRNA-1273 MRNA COVID-19 Vaccines as the Third Booster for the Patients with Underlying Cancer. Wolters Kluwer Medknow Publications.
Warning: These citations may not always be 100% accurate.